The relationship between repressive and defensive coping styles and monocyte, eosinophile, and serum glucose levels: Support for the opiod peptide hypothesis of repression

L. D. Janner, Gary E Schwartz, H. Leigh

Research output: Contribution to journalArticle

148 Citations (Scopus)

Abstract

The opioid peptide hypothesis of repression (1) predicts that repressive coping is associated with increased functional endorphin levels in the brain, which can result in decreased immunocompetence and hyperglycemia. In a random sample of 312 patients seen at a Yale Medical School outpatient clinic, significant main effects of coping style were found for monocyte and eosinophile counts, serum glucose levels, and self-reports of medication allergies. Specifically, repressive and defensive high-anxious patients demonstrated significantly decreased monocyte counts. In addition, repressive coping was associated with elevated eosinophile counts, serum glucose levels, and self-reported reactions to medications. This behavioral immunologic, and endocrine profile is consistent with the opioid peptide hypothesis, which provides an integrative framework for relating the attenuated emotional experience of pain and distress characteristic of repressive coping with reduced resistance to infectious and neoplastic disease.

Original languageEnglish (US)
Pages (from-to)567-575
Number of pages9
JournalPsychosomatic Medicine
Volume50
Issue number6
StatePublished - 1988
Externally publishedYes

Fingerprint

Opioid Peptides
Eosinophils
Monocytes
Endorphins
Immunocompetence
Glucose
Peptides
Ambulatory Care Facilities
Serum
Medical Schools
Hyperglycemia
Self Report
Communicable Diseases
Hypersensitivity
Pain
Brain

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Psychology(all)

Cite this

@article{3b49001bd01f4fda86ae76bde5460fe6,
title = "The relationship between repressive and defensive coping styles and monocyte, eosinophile, and serum glucose levels: Support for the opiod peptide hypothesis of repression",
abstract = "The opioid peptide hypothesis of repression (1) predicts that repressive coping is associated with increased functional endorphin levels in the brain, which can result in decreased immunocompetence and hyperglycemia. In a random sample of 312 patients seen at a Yale Medical School outpatient clinic, significant main effects of coping style were found for monocyte and eosinophile counts, serum glucose levels, and self-reports of medication allergies. Specifically, repressive and defensive high-anxious patients demonstrated significantly decreased monocyte counts. In addition, repressive coping was associated with elevated eosinophile counts, serum glucose levels, and self-reported reactions to medications. This behavioral immunologic, and endocrine profile is consistent with the opioid peptide hypothesis, which provides an integrative framework for relating the attenuated emotional experience of pain and distress characteristic of repressive coping with reduced resistance to infectious and neoplastic disease.",
author = "Janner, {L. D.} and Schwartz, {Gary E} and H. Leigh",
year = "1988",
language = "English (US)",
volume = "50",
pages = "567--575",
journal = "Psychosomatic Medicine",
issn = "0033-3174",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - The relationship between repressive and defensive coping styles and monocyte, eosinophile, and serum glucose levels

T2 - Support for the opiod peptide hypothesis of repression

AU - Janner, L. D.

AU - Schwartz, Gary E

AU - Leigh, H.

PY - 1988

Y1 - 1988

N2 - The opioid peptide hypothesis of repression (1) predicts that repressive coping is associated with increased functional endorphin levels in the brain, which can result in decreased immunocompetence and hyperglycemia. In a random sample of 312 patients seen at a Yale Medical School outpatient clinic, significant main effects of coping style were found for monocyte and eosinophile counts, serum glucose levels, and self-reports of medication allergies. Specifically, repressive and defensive high-anxious patients demonstrated significantly decreased monocyte counts. In addition, repressive coping was associated with elevated eosinophile counts, serum glucose levels, and self-reported reactions to medications. This behavioral immunologic, and endocrine profile is consistent with the opioid peptide hypothesis, which provides an integrative framework for relating the attenuated emotional experience of pain and distress characteristic of repressive coping with reduced resistance to infectious and neoplastic disease.

AB - The opioid peptide hypothesis of repression (1) predicts that repressive coping is associated with increased functional endorphin levels in the brain, which can result in decreased immunocompetence and hyperglycemia. In a random sample of 312 patients seen at a Yale Medical School outpatient clinic, significant main effects of coping style were found for monocyte and eosinophile counts, serum glucose levels, and self-reports of medication allergies. Specifically, repressive and defensive high-anxious patients demonstrated significantly decreased monocyte counts. In addition, repressive coping was associated with elevated eosinophile counts, serum glucose levels, and self-reported reactions to medications. This behavioral immunologic, and endocrine profile is consistent with the opioid peptide hypothesis, which provides an integrative framework for relating the attenuated emotional experience of pain and distress characteristic of repressive coping with reduced resistance to infectious and neoplastic disease.

UR - http://www.scopus.com/inward/record.url?scp=0024245433&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024245433&partnerID=8YFLogxK

M3 - Article

C2 - 2853404

AN - SCOPUS:0024245433

VL - 50

SP - 567

EP - 575

JO - Psychosomatic Medicine

JF - Psychosomatic Medicine

SN - 0033-3174

IS - 6

ER -